Mark Kosenko

Mr. Mark Kosenko


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2025 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
MKMark Kosenko
Mark Kosenko
VRVeronika Rogozhina
Veronika Rogozhina
TETamerlan Erdniev
Tamerlan Erdniev
ASArmen K Shakaryan
Armen K Shakaryan
DTDmitry Tumurov
Dmitry Tumurov
DMDaniel Munblit
Daniel Munblit
Background: Botulism is a life-threatening neuroparalytic disease caused by botulinum neurotoxins. While its acute phase has been extensively studied, long-term sequelae following recovery remain insufficiently explored. This systematic review aims to comprehensively assess and synthesize available evidence on post-botulism sequelae to improve understanding and guide future research. Methods: A systematic search was conducted in MEDLINE, EMBASE via Ovid, and Web of Science from inception to 24 June 2024. Eligible studies included observational studies, case series, and case reports describing post-recovery symptoms in individuals diagnosed with foodborne, wound, or infant botulism, excluding iatrogenic cases. The risk of bias was assessed using the Critical Appraisal Skills Programme (CASP) checklists. Results: Out of 340 screened records, 9 studies met inclusion criteria, comprising 2 case-control studies (n = 230 botulism cases, n = 669 controls) and 7 cohort studies (n = 185 botulism cases). Most studies reported some short- and/or long-term consequences of botulism. Among 3 studies homogeneously reporting sequelae symptomatology, the most frequently reported long-term symptoms included fatigue (66.2%, range 47.9%–84.6%), limitations in vigorous activities (55.8%, range 47.6%–64.0%), general weakness (57.1%, range 43.1%–76.9%), and dyspnea (42.9%, range 18.0%–92.3%). In some patients, psychosocial dysfunction persisted longer than physical impairments, over the 6-year period post intoxication. Two studies provided comparative data with control groups, demonstrating significantly higher prevalence of fatigue, weakness, and impaired health perception in botulism survivors. Additionally, 14 case reports and case series (n = 43 individuals) reported similar patterns with dyspnea, fatigue, and autonomic dysfunction among the most reported sequelae. Conclusions: This systematic review highlights significant long-term sequelae among botulism survivors, particularly fatigue, respiratory impairment, and psychosocial dysfunction. While recovery trajectories suggest improvement over time, persistent symptoms may impact quality of life. Standardized outcome measures and longitudinal studies are needed to elucidate the burden of post-botulism sequelae further and inform clinical management strategies.

10 March 2026 in Clinical Infectious Diseases
Verified
Journal Article
Open access
MKMark Kosenko
Mark Kosenko
LDLilit Davtian
Lilit Davtian
EIEkaterina Iakovleva
Ekaterina Iakovleva
MAMukhammad Ashurov
Mukhammad Ashurov
DPDmitrii Podgalo
Dmitrii Podgalo
Danilo BuonsensoDanilo Buonsenso
Danilo Buonsenso
Background: We conducted a systematic review and meta-analysis to compare effectiveness and safety of 9 months of isoniazid (9H) versus shorter rifamycin-containing regimens for treating latent tuberculosis infection (TBI) in children. Methods: We systematically searched MEDLINE, Embase, and Cochrane Central Register of Controlled Trials to June 2025 for randomized, controlled trials (RCTs) and cohort studies that compared regimens that were shorter than 9 months of isoniazid in children aged 1–18 years. Outcomes were development of TB disease, treatment completion, and adverse events. Risk of bias was assessed using RoB 2.0 and the Risk Of Bias In Non-Randomized Studies - of Interventions (ROBINS-I) tool; certainty of evidence was graded using Grading of Recommendations Assessment, Development, and Evaluation (GRADE). Results: Five RCTs and 7 nonrandomized studies that enrolled approximately 2950 children in trials and >25 000 in observational cohorts were included. In pooled analysis of 3 RCTs, shorter rifamycin-containing regimens resulted in little to no difference in development of TB disease compared with 9H (odds ratio [OR], 0.19; 95% confidence interval [CI], .03–1.12; moderate-certainty evidence). Treatment completion was probably higher with shorter regimens (OR, 0.51; 95% CI, .42–0.62; moderate-certainty evidence). Adverse events were similar between groups, but evidence is uncertain (low-certainty evidence). Observational data were consistent with these findings, showing higher completion rates and lower hepatotoxicity with shorter treatments. Conclusions: Shorter rifamycin-containing regimens for pediatric TBI probably increase treatment completion and have similar safety outcomes, with no important difference in development of TB disease compared with the standard regimen. These findings support current guideline recommendations that favor shorter regimens in children.

28 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SYSophie Yacoub
Sophie Yacoub
ADAnastasiia Demidova
Anastasiia Demidova
XCXin Hui S Chan
Xin Hui S Chan
AAAli Ajam
Ali Ajam
DBDina Baimukhambetova
Dina Baimukhambetova
DMDaniel Munblit
Daniel Munblit
Dengue, caused by any one of four distinct virus serotypes, is the most rapidly spreading mosquito-borne viral disease worldwide. It is a primary arboviral infection with increasing global incidence, driven by climate change, urbanisation, and the expanding range of Aedes mosquito vectors. Despite growing research interest, outcome and measurement instrument heterogeneity in dengue clinical trials remains high, limiting comparability and evidence synthesis. This project aimed to develop a globally relevant Core Outcome Measurement Set (COMS) for use in dengue clinical trials through international consensus.This consensus study followed COMET and COS-STAD guidelines and was conducted in two phases. Phase I focused on developing a core outcome set (COS) through six steps: (1) a systematic literature review; (2) qualitative interviews with people with lived experience of dengue; (3) review by the management group and steering committee; (4) a two-round modified Delphi survey and structured online consensus meetings to finalise the COS for ‘hospitalised’ and ‘early’ stages of dengue. Input from critical care experts informed recommendations for the ‘ICU/HDU’ COS. Phase II involved: (5) targeted review of outcome measurement instruments; and (6) a hybrid international consensus workshop to finalise the COMS.The agreed COMS for ‘hospitalised’ dengue included seven outcomes; the ‘early’ COS includes these plus four more. For critical care trials, use of existing ICU-specific COS was recommended. Unified definitions were developed for nine clinician-reported outcomes.The DEN-CORE COMS provides a consensus-based framework for harmonising outcome selection and measurement in dengue trials, improving comparability and supporting policy and clinical decision-making.

2 July 2024 in Digital Diagnostics
Verified
Journal Article
Open access
PDF file
MKMark Kosenko
Mark Kosenko
Gleb B NemkovskiyGleb B Nemkovskiy
Gleb B Nemkovskiy
OTOlesya Yu. Tsvetkova
Olesya Yu. Tsvetkova
IAIvan D. Akinfeev
Ivan D. Akinfeev
VDValeriia A. Dolgova
Valeriia A. Dolgova
ЦЮЦветкова Олеся Юрьевна
Цветкова Олеся Юрьевна
BACKGROUND: The application of videofixation technologies in embryology is developing significantly. These technologies permit the objective analysis of the process of early embryogenesis of each cultured embryo without the necessity of removing the culture cup from the incubator. Timelapse technologies in routine practice allow for the guaranteed detection of embryo developmental pathologies that are inaccessible to traditional developmental monitoring methods [1, 2]. Nevertheless, the annotation and manual evaluation of all frames captured during the cultivation process can be a time-consuming process. Furthermore, video fixation itself does not eliminate the issue of objectivizing the quality of interpretation of the obtained images [3]. Intelligent technologies, in particular, solutions developed with the use of machine learning, are successfully employed in the resolution of such problems. AIM: The aim of this study is to develop a system for the automated analysis of the morphokinetic state of the human embryo with the aim of assessing its capacity for implantation. MATERIALS AND METHODS: The data were collected at the Family Medical Center (Ufa, Russia) and the Clinical Hospital IDK of the Mother and Child Group of Companies (Samara, Russia). Digital images of the period of preimplantation development of human embryos up to the blastocyst stage (days 0–6 from insemination) were obtained using an incubator for in vitro fertilization laboratories, the EmbryoVisor, with a timelapse (hyperlapse) video fixation system. Embryos were cultured individually in special micro-well WOW dishes (Vitrolife, Sweden). The data set was labelled using Label Studio Community Edition software. A recurrent convolutional neural network was selected to analyse the data and trained using multiple images. RESULTS: The development of the automatic analysis system is based on the classification of the morphokinetic state of the embryo according to the stages of embryogenesis: fertilization, fragmentation, morula formation, and blastocyst formation. Segmentation of multiple objects, such as pronuclei and polar bodies at the fertilization stage or blastomeres at the fragmentation stage, will be performed depending on a certain stage of development. We plan to build a binary classification of the presence of additional features (multinucleation, heterogeneity of the endoplasmic network), classification/regression of additional features (so, fragmentation can be estimated as discrete ranges or absolute values). The result is a system for labeling the morphodynamic profile of an embryo using deep learning. This method automates and accelerates the analysis process, which previously required significant time and human resources. CONCLUSIONS: It is anticipated that the developed system of automatic analysis of morphokinetic state of embryos will simplify the process of evaluating the quality of human embryos in in vitro fertilization laboratories, reducing the time and resources spent on this process. Furthermore, it will enhance the accuracy and reliability of assessing the implantation ability of embryos and could potentially serve as the foundation for the development of a support system for medical decision-making in embryology.